D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
EIGR holding history
Eiger BioPharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EIGR overviewAll 13F holders of EIGRFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −46,496−100.0% | Sold out | Holders |
| Q4 2022 | 46,496 | $54.9K | <0.1% | −55,708−54.5% | Reduced | Holders |
| Q3 2022 | 102,204 | $770.0K | <0.1% | −154,609−60.2% | Reduced | Holders |
| Q2 2022 | 256,813 | $1.62M | <0.1% | −79,234−23.6% | Reduced | Holders |
| Q1 2022 | 336,047 | $2.79M | <0.1% | +307,080+1,060.1% | Added | Holders |
| Q4 2021 | 28,967 | $150.0K | <0.1% | +28,967 | New | Holders |